EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RIPK3 Protects Against Endothelial Activation and Vascular Permeability in a Mouse Model of Ischemia-Reperfusion Injury

Charmain F Johnson iD, Christopher M Schafer iD, Kathryn Y Burge iD, Brian G Coon, Hala Chaaban iD, Courtney T Griffin iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026

DOI: 10.1161/atvbaha.125.322977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Charmain F Johnson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City (C.F.J., C.M.S., B.G.C., C.T.G.). Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinases, Reperfusion Injury, Capillary Permeability, Endothelial Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Heart Association-American Stroke Association, NIGMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: RIPK3 (receptor-interacting protein kinase 3) has context-specific roles that are frequently associated with cellular damage and death. We previously found that hypoxia can trigger elevated levels of RIPK3 in endothelial cells (ECs), which contributes to lethal vascular rupture during mouse embryonic development. However, it is unknown whether elevated RIPK3 likewise compromises endothelial barrier function in adult vasculature under hypoxic conditions such as ischemia-reperfusion (I/R) injury. METHODS: Twelve-week-old male and female littermate control or inducible EC-specific Ripk3 knockout ( Ripk3 iECKO ) mice were exposed to surgical intestinal I/R injury. Clodronate liposomes were used to reduce circulating monocytes in vivo. Immortalized murine EC (MS1 [mile sven 1) and murine macrophage (BMA3.1A7 [bone marrow A clone 3.187]) lines were used for in vitro experiments. RESULTS: Ripk3 iECKO mice displayed an unexpected increase in small intestinal vascular permeability after I/R injury, rather than the decrease we predicted. Subsequent analyses using multiplex cytokine assays revealed significantly elevated levels of IL-6 (interleukin-6) in the serum and small intestinal tissue of I/R-injured Ripk3 iECKO mice. Upon TNFα (tumor necrosis factor-alpha) stimulation of immortalized murine Ripk3 knockout ECs grown in vitro, we found increased transcription and secretion of IL-6. These cells also expressed elevated levels of VCAM-1 (vascular cell adhesion molecule-1), which was likewise upregulated in the small intestines of Ripk3 iECKO mice. Using an IL-6 neutralizing antibody, we found that IL-6 triggered VCAM-1 elevation in Ripk3 knockout cells. This VCAM-1 expression correlated with enhanced macrophage binding to Ripk3 knockout cells and increased accumulation of leukocytes in Ripk3 iECKO small intestines following I/R injury. Importantly, reduction of circulating monocytes with clodronate liposomes led to rescue of IR injury–induced vascular permeability in Ripk3 iECKO mice. CONCLUSIONS: Endothelial RIPK3 suppresses EC activation and inflammation associated with IL-6 and VCAM-1 elevation to protect the vascular barrier in the context of intestinal I/R injury. Thus, endothelial RIPK3 plays surprisingly beneficial roles that reduce I/R injury–induced vascular dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor-Interacting Protein Serine-Threonine KinasesReperfusion InjuryCapillary PermeabilityEndothelial CellsAnimalsMice, KnockoutDisease Models, AnimalMaleFemaleMice, Inbred C57BLInterleukin-6Signal TransductionMiceCells, CulturedMacrophagesVascular Cell Adhesion Molecule-1Tumor Necrosis Factor-alphaInflammation Mediators

Stichwörter der Autor:innen

cytokinesinflammationinterleukin-6micemonocytes

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesRipk3 protein, mouseInterleukin-6Vascular Cell Adhesion Molecule-1Tumor Necrosis Factor-alphaInflammation Mediatorsinterleukin-6, mouse

Autor:innen und Institutionen

  • Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City (C.F.J., C.M.S., B.G.C., C.T.G.).
  • Now with Department of Biology, University of Central Oklahoma, Edmond (C.M.S.).
  • Neonatal-Perinatal Medicine, Department of Pediatrics (K.Y.B., H.C.), University of Oklahoma Health Sciences Center, Oklahoma City.
  • Department of Cell Biology (B.G.C., C.T.G.), University of Oklahoma Health Sciences Center, Oklahoma City.

ORCID-Profile: Charmain F Johnson, Christopher M Schafer, Kathryn Y Burge, Hala Chaaban, Courtney T Griffin

Förderung

  • American Heart Association-American Stroke Association
  • NIGMS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Johnson, C. F., Schafer, C. M., Burge, K. Y., Coon, B. G., Chaaban, H., & Griffin, C. T. (2026). RIPK3 Protects Against Endothelial Activation and Vascular Permeability in a Mouse Model of Ischemia-Reperfusion Injury. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.322977

Vancouver

Johnson CF, Schafer CM, Burge KY, Coon BG, Chaaban H, Griffin CT. RIPK3 Protects Against Endothelial Activation and Vascular Permeability in a Mouse Model of Ischemia-Reperfusion Injury. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.322977

BibTeX
@article{Johnson2026,
  author = {Johnson, Charmain F and Schafer, Christopher M and Burge, Kathryn Y and Coon, Brian G and Chaaban, Hala and Griffin, Courtney T},
  title = {RIPK3 Protects Against Endothelial Activation and Vascular Permeability in a Mouse Model of Ischemia-Reperfusion Injury},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.125.322977}
}
Kostenlos starten →